Ganaxolone in seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: a profile of its use in the USA Susan J. KeamZaina T. Al-Salama Adis Drug Q&a 30 January 2023 Pages: 81 - 88
Nivolumab/relatlimab in advanced melanoma: a profile of its use Arnold Lee Adis Drug Q&A 21 February 2023 Pages: 89 - 95
Growth-related effects of antiseizure medications are of concern in children with epilepsy Esther S. KimArnold Lee Drug Reactions and Interactions 26 January 2023 Pages: 96 - 101
Take a fresh look at diet and atopic dermatitis Caroline FentonArnold Lee Practical Issues and Updates 24 January 2023 Pages: 102 - 106
Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management Caroline FentonConnie Kang Practical Issues and Updates 17 February 2023 Pages: 107 - 113
The role of community pharmacists in optimising patient self-management of constipation: an inter-disciplinary consensus view Thomas FrielingEric MartinChristian Ude Current Opinion Open access 31 January 2023 Pages: 114 - 123